PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
SYM vs. PATH
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between SYM and PATH is 0.28, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.3

Performance

SYM vs. PATH - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Symbotic Inc (SYM) and UiPath Inc. (PATH). The values are adjusted to include any dividend payments, if applicable.

-20.00%0.00%20.00%40.00%60.00%SeptemberOctoberNovemberDecember2025February
13.36%
23.23%
SYM
PATH

Key characteristics

Sharpe Ratio

SYM:

-0.43

PATH:

-0.81

Sortino Ratio

SYM:

-0.12

PATH:

-0.90

Omega Ratio

SYM:

0.98

PATH:

0.86

Calmar Ratio

SYM:

-0.53

PATH:

-0.49

Martin Ratio

SYM:

-1.03

PATH:

-0.98

Ulcer Index

SYM:

36.92%

PATH:

43.46%

Daily Std Dev

SYM:

88.16%

PATH:

52.74%

Max Drawdown

SYM:

-71.89%

PATH:

-87.61%

Current Drawdown

SYM:

-57.41%

PATH:

-82.50%

Fundamentals

Market Cap

SYM:

$16.31B

PATH:

$8.21B

EPS

SYM:

-$0.14

PATH:

-$0.16

PEG Ratio

SYM:

4.40

PATH:

0.88

Total Revenue (TTM)

SYM:

$1.91B

PATH:

$1.01B

Gross Profit (TTM)

SYM:

$255.60M

PATH:

$823.02M

EBITDA (TTM)

SYM:

-$105.18M

PATH:

-$182.16M

Returns By Period

In the year-to-date period, SYM achieves a 14.13% return, which is significantly lower than PATH's 17.23% return.


SYM

YTD

14.13%

1M

-9.07%

6M

7.51%

1Y

-37.11%

5Y*

N/A

10Y*

N/A

PATH

YTD

17.23%

1M

14.44%

6M

23.24%

1Y

-40.30%

5Y*

N/A

10Y*

N/A

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

SYM vs. PATH — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

SYM
The Risk-Adjusted Performance Rank of SYM is 2323
Overall Rank
The Sharpe Ratio Rank of SYM is 2323
Sharpe Ratio Rank
The Sortino Ratio Rank of SYM is 2727
Sortino Ratio Rank
The Omega Ratio Rank of SYM is 2828
Omega Ratio Rank
The Calmar Ratio Rank of SYM is 1515
Calmar Ratio Rank
The Martin Ratio Rank of SYM is 2020
Martin Ratio Rank

PATH
The Risk-Adjusted Performance Rank of PATH is 1313
Overall Rank
The Sharpe Ratio Rank of PATH is 77
Sharpe Ratio Rank
The Sortino Ratio Rank of PATH is 1212
Sortino Ratio Rank
The Omega Ratio Rank of PATH is 99
Omega Ratio Rank
The Calmar Ratio Rank of PATH is 1717
Calmar Ratio Rank
The Martin Ratio Rank of PATH is 2222
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

SYM vs. PATH - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Symbotic Inc (SYM) and UiPath Inc. (PATH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for SYM, currently valued at -0.47, compared to the broader market-2.000.002.004.00-0.47-0.81
The chart of Sortino ratio for SYM, currently valued at -0.21, compared to the broader market-6.00-4.00-2.000.002.004.006.00-0.21-0.90
The chart of Omega ratio for SYM, currently valued at 0.97, compared to the broader market0.501.001.502.000.970.86
The chart of Calmar ratio for SYM, currently valued at -0.58, compared to the broader market0.002.004.006.00-0.58-0.49
The chart of Martin ratio for SYM, currently valued at -1.12, compared to the broader market-10.000.0010.0020.0030.00-1.12-0.98
SYM
PATH

The current SYM Sharpe Ratio is -0.43, which is higher than the PATH Sharpe Ratio of -0.81. The chart below compares the historical Sharpe Ratios of SYM and PATH, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.00-0.80-0.60-0.40-0.200.000.20SeptemberOctoberNovemberDecember2025February
-0.47
-0.81
SYM
PATH

Dividends

SYM vs. PATH - Dividend Comparison

Neither SYM nor PATH has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

SYM vs. PATH - Drawdown Comparison

The maximum SYM drawdown since its inception was -71.89%, smaller than the maximum PATH drawdown of -87.61%. Use the drawdown chart below to compare losses from any high point for SYM and PATH. For additional features, visit the drawdowns tool.


-90.00%-80.00%-70.00%-60.00%-50.00%-40.00%SeptemberOctoberNovemberDecember2025February
-57.41%
-82.50%
SYM
PATH

Volatility

SYM vs. PATH - Volatility Comparison

Symbotic Inc (SYM) has a higher volatility of 29.29% compared to UiPath Inc. (PATH) at 15.92%. This indicates that SYM's price experiences larger fluctuations and is considered to be riskier than PATH based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


10.00%20.00%30.00%40.00%50.00%60.00%SeptemberOctoberNovemberDecember2025February
29.29%
15.92%
SYM
PATH

Financials

SYM vs. PATH - Financials Comparison

This section allows you to compare key financial metrics between Symbotic Inc and UiPath Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab